510(k) device
Inratio
Hemosense, Inc. · Test, Time, Prothrombin (GJS, Class II) · First FDA decision May 6, 2002, newest May 6, 2002Anemia, clotting and blood disordersStroke prevention in atrial fibrillation
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
3
Naming "Inratio"
MAUDE reports
1,202
Brand "Inratio", since 2015
PubMed studies
19
Mentioning "Inratio"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Inratio
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- INRATIO510(k)
K020679 · Decided May 6, 2002 · 63 days after receipt
Device type: Test, Time, Prothrombin (GJS) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Home Prothrombin Time/International Normalized Ratio (PT/INR) Monitoring for Anticoagulation ManagementNational determinationOn the books190.11Updated Nov 4, 2026
- Prothrombin Time (PT)National determinationOn the books190.17Updated Oct 1, 2026
- Prothrombin Time (INR) Monitor for Home Anticoagulation ManagementNational analysisReview closedCAG-00087RUpdated Sep 21, 2026
- Prothrombin Time and Partial Thromboplastin Time (Revision of ICD-9-CM Codes for Swelling of Limb)Coding analysisReview closedCAG-00201NUpdated Sep 15, 2026
- Prothrombin Time and Partial Thromboplastin Time (Revision of ICD-9-CM Codes for Pre-operative Examinations)Coding analysisReview closedCAG-00184NUpdated Sep 15, 2026
- Prothrombin Time and Fecal Occult Blood (Revision of ICD-9-CM Codes for Injury to Gastrointestinal Tract)Coding analysisReview closedCAG-00187NUpdated Sep 15, 2026
- Prothrombin Time (PT) NCD 190.17 (Addition of ICD-9-CM diagnosis code 197.7 Secondary Malignant Neoplasm of Liver)Coding analysisReview closedCAG-00404NUpdated Sep 15, 2026
- Prothrombin Time (PT) and Partial Thromboplastin Time (PTT) tests (Removal of Unspecified Joint Replacements)Coding analysisReview closedCAG-00246NUpdated Sep 15, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Inratio", any status and sponsor, newest update first.
- Benefit of Self-monitoring of Anticoagulation InstrumentPivotal-lookingCompleted
University Hospital, BordeauxAcademic, hospital or other
NCT00506870 · 919 participants · Start Jun 2007 · Primary completion Feb 2010
Device: INRatio / Coaguchek XS · For: Mechanical Prosthetic Heart Valve Implantation; Patient Self Monitoring of Oral Anticoagulent Therapy
Sites: Pessac, France
- Improved Time in Therapeutic Range With Patient Self-Testing of Their INR Compared to Usual CarePivotal-lookingCompleted
Mayo ClinicAcademic, hospital or other
NCT00703963 · 200 participants · Start Mar 2007 · Primary completion Mar 2009
Device: INRatio monitor by Hemosense · For: Management of Anticoagulation
Sites: Rochester, Minnesota
University Hospital, CaenAcademic, hospital or other
NCT01930916 · 150 participants (planned) · Start Oct 2012 · Primary completion Nov 2014
Device: INR capillary measurement with INRatio 2 device · For: Blood Coagulation Disorders; Blood Coagulation Disorder With Prolonged Bleeding Time; Blood Coagulation Disorder With Prolonged Coagulation Time
Sites: Amiens, France; Caen, France; Lille, France · 4 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Inratio", and for the whole product code for context.
This brand
1,202 reports: 954 malfunction, 226 injury, 16 death
Whole product code GJS
12,207 reports: 11,507 malfunction, 644 injury, 34 death
Newest reports for this brand
- INRATIOInjury
MW5137240 · Received Aug 12, 2023
Device type: Test, Time, Prothrombin (GJS)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Transient Ischemic Attack
- INRATIO TEST KITS 12Injury
2027969-2019-00429 · Received Sep 19, 2019 · Event dated Sep 16, 2013
Device type: Test, Time, Prothrombin (GJS)
Device problem as coded: Low Test Results
Patient problem as coded: No Information
- INRATIO TEST KITS 12Malfunction
2027969-2019-00430 · Received Sep 19, 2019 · Event dated Sep 18, 2013
Device type: Test, Time, Prothrombin (GJS)
Device problem as coded: Low Test Results
Patient problem as coded: No Information
- INRATIO TEST KITS 48Malfunction
2027969-2019-00436 · Received Sep 19, 2019
Device type: Test, Time, Prothrombin (GJS)
Device problem as coded: Incorrect, Inadequate or Imprecise Result or Readings
Patient problem as coded: No Information
- INRATIO TEST KITMalfunction
2027969-2019-00433 · Received Sep 19, 2019
Device type: Test, Time, Prothrombin (GJS)
Device problem as coded: Low Readings
Patient problem as coded: No Information
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2355-2016 · Started Jul 11, 2016 · Posted by FDA Aug 19, 2016
Reason given: Alere San Diego is initiating a voluntary recall for the Alere INRatio/INRatio2 PT/INR Monitoring Systems (Test Strips and Meters). This action is being initiated as a result of patients who had a therapeutic or near-therapeutic INR with the Alere INRatio/INRatio2 PT/INR Monitoring System but a significantly higher...
Cause as FDA categorized it: Other · Device type: Test, Time, Prothrombin (GJS)
Z-2356-2016 · Started Jul 11, 2016 · Posted by FDA Aug 19, 2016
Reason given: Alere San Diego is initiating a voluntary recall for the Alere INRatio/INRatio2 PT/INR Monitoring Systems (Test Strips and Meters). This action is being initiated as a result of patients who had a therapeutic or near-therapeutic INR with the Alere INRatio/INRatio2 PT/INR Monitoring System but a significantly higher...
Cause as FDA categorized it: Other · Device type: Test, Time, Prothrombin (GJS)
Z-0880-2015 · Started Dec 5, 2014 · Posted by FDA Jan 3, 2015
Reason given: In certain cases, an INRatio PT/INR Monitor system may provide an INR result that is significantly lower than a result obtained using a reference INR system (laboratory method). This issue can arise if the patient has certain medical conditions. It can also occur if the instructions in the labeling for performing the...
Cause as FDA categorized it: Under Investigation by firm · Device type: Test, Time, Prothrombin (GJS)
Z-0881-2015 · Started Dec 5, 2014 · Posted by FDA Jan 3, 2015
Reason given: In certain cases, an INRatio PT/INR Monitor system may provide an INR result that is significantly lower than a result obtained using a reference INR system (laboratory method). This issue can arise if the patient has certain medical conditions. It can also occur if the instructions in the labeling for performing the...
Cause as FDA categorized it: Under Investigation by firm · Device type: Test, Time, Prothrombin (GJS)
Z-0188-2012 · Started Oct 11, 2011 · Posted by FDA Nov 16, 2011
Reason given: Alere has initiated a recall of the Professional Disposables International (PDI) alcohol prep products due to the potential presence of low levels of the microorganism Bacillus cereus.
Cause as FDA categorized it: Material/Component Contamination · Device type: Pad, Alcohol, Device Disinfectant (LKB)
Z-0132-06 · Started Sep 7, 2005 · Posted by FDA Nov 15, 2005
Reason given: A software problem that may cause the INRatio meter to incorrectly display 'INR>7.5' test message under a particular use condition.
Cause as FDA categorized it: Other · Device type: Test, Time, Prothrombin (GJS)
Published research
The most relevant PubMed records for "Inratio"[tiab]. The summary above synthesizes these.
- Portable INR analysis prior to dental procedures: technique instruction outcomes for senior dental students.
Hall DL, Mohammad AR · Compend Contin Educ Dent · 2011
- Comparison of the international normalized ratio levels obtained by portable coagulometer and laboratory in a clinic specializing in oral anticoagulation.
Meneghelo ZM, Barroso CM, Liporace IL, et al. · Int J Lab Hematol · 2015Comparative Study, Research Support, Non-U.S. Gov't
- Clinically significant differences between point-of-care analysers and a standard analyser for monitoring the International Normalized Ratio in oral anticoagulant therapy: a multi-instrument evaluation in a hospital outpatient setting.
Moore GW, Henley A, Cotton SS, et al. · Blood Coagul Fibrinolysis · 2007Evaluation Study
- Utility of a point-of-care device for rapid determination of prothrombin time in trauma patients: a preliminary study.
David JS, Levrat A, Inaba K, et al. · J Trauma Acute Care Surg · 2012Comparative Study
- Establishment of a novel method for differentiating into dopaminergic neurons using charged hydrogels.
Fan B, Tanikawa S, Wang L, et al. · Biochem Biophys Res Commun · 2025Research Support, Non-U.S. Gov't
- Correlation Between Home INR and Core Laboratory INR in Patients Supported with Continuous-Flow Left Ventricular Assist Devices.
Dionizovik-Dimanovski M, Levin AP, Fried J, et al. · ASAIO J · 2015
- A randomized trial comparing INR monitoring devices in patients with anticoagulation self-management: evaluation of a novel error-grid approach.
Hemkens LG, Hilden KM, Hartschen S, et al. · J Thromb Thrombolysis · 2008Comparative Study, Randomized Controlled Trial
- Effect of coagulation factors on discrepancies in International Normalized Ratio results between instruments.
Sølvik UØ, Røraas TH, Petersen PH, et al. · Clin Chem Lab Med · 2012Research Support, Non-U.S. Gov't
- Results of the first randomized French study evaluating self-testing of the International Normalized Ratio.
Azarnoush K, Camilleri L, Aublet-Cuvelier B, et al. · J Heart Valve Dis · 2011Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Inaccuracy of point-of-care international normalized ratio in rivaroxaban-treated patients.
Baruch L, Sherman O · Ann Pharmacother · 2013Case Reports
- Analytical performance of the new coagulation monitoring system INRatio for the determination of INR compared with the coagulation monitor Coaguchek S and an established laboratory method.
Taborski U, Braun SL, Völler H · J Thromb Thrombolysis · 2004Comparative Study, Multicenter Study
- Variability of PT-INR values measured by point of care devices INRatio/INRatio 2 and CoaguChek XS and standard laboratory method. A cross-sectional study.
Komatsu C, Iseki H, Goto S, et al. · Arch Med Sci · 2026
Other devices of this type
Also filed under product code GJS.
- microINR SystemIline Microsystems, S.L. · 510(k) 2025
- CoaguChek XS Plus SystemRoche Diagnostics · 510(k) 2025
- Coag-Sense Prothrombin (PT) / INR Monitoring System for Patient Self-TestingCoagusense, Inc. · 510(k) 2022
- CoaguChek XS Pro SystemRoche Diagnostics · 510(k) 2018
- Hemosil Recombiplastin 2G (8 Ml Vial)Instrumentation Laboratory CO · 510(k) 2014
- Coaguchek Xs SystemRoche Diagnostics Corp. · 510(k) 2007
- Xprecia Prime Coagulation SystemUniversal Biosensors Pty, Ltd. · 510(k) 2024
- i-STAT PTplus Cartridge with the i-STAT 1 SystemAbbott Laboratories · 510(k) 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.